TISSIUM receives FDA approval for its polymerizable vascular sealant
TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of medical procedures: to reconstruct damaged tissue. The medtech company developed a proprietary technology, called biomorphic programmable polymers, to transform the way tissues…
Read more



